These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 35216089)
1. Inflammation Is Present, Persistent and More Sensitive to Proinflammatory Triggers in Celiac Disease Enterocytes. Porpora M; Conte M; Lania G; Bellomo C; Rapacciuolo L; Chirdo FG; Auricchio R; Troncone R; Auricchio S; Barone MV; Nanayakkara M Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216089 [TBL] [Abstract][Full Text] [Related]
2. Enterocyte proliferation and signaling are constitutively altered in celiac disease. Nanayakkara M; Lania G; Maglio M; Kosova R; Sarno M; Gaito A; Discepolo V; Troncone R; Auricchio S; Auricchio R; Barone MV PLoS One; 2013; 8(10):e76006. PubMed ID: 24204586 [TBL] [Abstract][Full Text] [Related]
3. Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking. Barone MV; Zanzi D; Maglio M; Nanayakkara M; Santagata S; Lania G; Miele E; Ribecco MT; Maurano F; Auricchio R; Gianfrani C; Ferrini S; Troncone R; Auricchio S PLoS One; 2011 Feb; 6(2):e17039. PubMed ID: 21364874 [TBL] [Abstract][Full Text] [Related]
4. P31-43, an undigested gliadin peptide, mimics and enhances the innate immune response to viruses and interferes with endocytic trafficking: a role in celiac disease. Nanayakkara M; Lania G; Maglio M; Auricchio R; De Musis C; Discepolo V; Miele E; Jabri B; Troncone R; Auricchio S; Barone MV Sci Rep; 2018 Jul; 8(1):10821. PubMed ID: 30018339 [TBL] [Abstract][Full Text] [Related]
6. Constitutive alterations in vesicular trafficking increase the sensitivity of cells from celiac disease patients to gliadin. Lania G; Nanayakkara M; Maglio M; Auricchio R; Porpora M; Conte M; De Matteis MA; Rizzo R; Luini A; Discepolo V; Troncone R; Auricchio S; Barone MV Commun Biol; 2019; 2():190. PubMed ID: 31123714 [TBL] [Abstract][Full Text] [Related]
7. Targeting of gliadin peptides, CD8, alpha/beta-TCR, and gamma/delta-TCR to Golgi complexes and vacuoles within celiac disease enterocytes. Zimmer KP; Naim H; Weber P; Ellis HJ; Ciclitira PJ FASEB J; 1998 Oct; 12(13):1349-57. PubMed ID: 9761778 [TBL] [Abstract][Full Text] [Related]
8. Pivotal Role of Inflammation in Celiac Disease. Barone MV; Auricchio R; Nanayakkara M; Greco L; Troncone R; Auricchio S Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806180 [TBL] [Abstract][Full Text] [Related]
9. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease. Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630 [TBL] [Abstract][Full Text] [Related]
10. PTPRK, an EGFR Phosphatase, Is Decreased in CeD Biopsies and Intestinal Organoids. Nanayakkara M; Bellomo C; Furone F; Maglio M; Marano A; Lania G; Porpora M; Nicoletti M; Auricchio S; Barone MV Cells; 2022 Dec; 12(1):. PubMed ID: 36611909 [TBL] [Abstract][Full Text] [Related]
11. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. Derikx JP; Vreugdenhil AC; Van den Neucker AM; Grootjans J; van Bijnen AA; Damoiseaux JG; van Heurn LW; Heineman E; Buurman WA J Clin Gastroenterol; 2009 Sep; 43(8):727-33. PubMed ID: 19359998 [TBL] [Abstract][Full Text] [Related]
12. An undigested gliadin peptide activates innate immunity and proliferative signaling in enterocytes: the role in celiac disease. Nanayakkara M; Lania G; Maglio M; Discepolo V; Sarno M; Gaito A; Troncone R; Auricchio S; Auricchio R; Barone MV Am J Clin Nutr; 2013 Oct; 98(4):1123-35. PubMed ID: 23966426 [TBL] [Abstract][Full Text] [Related]
13. A celiac cellular phenotype, with altered LPP sub-cellular distribution, is inducible in controls by the toxic gliadin peptide P31-43. Nanayakkara M; Kosova R; Lania G; Sarno M; Gaito A; Galatola M; Greco L; Cuomo M; Troncone R; Auricchio S; Auricchio R; Barone MV PLoS One; 2013; 8(11):e79763. PubMed ID: 24278174 [TBL] [Abstract][Full Text] [Related]
14. Additional value of serum I-FABP levels for evaluating celiac disease activity in children. Vreugdenhil AC; Wolters VM; Adriaanse MP; Van den Neucker AM; van Bijnen AA; Houwen R; Buurman WA Scand J Gastroenterol; 2011 Dec; 46(12):1435-41. PubMed ID: 22029621 [TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Yokoyama S; Watanabe N; Sato N; Perera PY; Filkoski L; Tanaka T; Miyasaka M; Waldmann TA; Hiroi T; Perera LP Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15849-54. PubMed ID: 19805228 [TBL] [Abstract][Full Text] [Related]
16. Gluten induces coeliac-like disease in sensitised mice involving IgA, CD71 and transglutaminase 2 interactions that are prevented by probiotics. Papista C; Gerakopoulos V; Kourelis A; Sounidaki M; Kontana A; Berthelot L; Moura IC; Monteiro RC; Yiangou M Lab Invest; 2012 Apr; 92(4):625-35. PubMed ID: 22330344 [TBL] [Abstract][Full Text] [Related]
17. Interleukin 18 maintains a long-standing inflammation in coeliac disease patients. León AJ; Garrote JA; Blanco-Quirós A; Calvo C; Fernández-Salazar L; Del Villar A; Barrera A; Arranz E Clin Exp Immunol; 2006 Dec; 146(3):479-85. PubMed ID: 17100768 [TBL] [Abstract][Full Text] [Related]
18. Intestinal T-cell responses in celiac disease - impact of celiac disease associated bacteria. Sjöberg V; Sandström O; Hedberg M; Hammarström S; Hernell O; Hammarström ML PLoS One; 2013; 8(1):e53414. PubMed ID: 23326425 [TBL] [Abstract][Full Text] [Related]
19. Intraepithelial lymphocyte immunophenotype: a useful tool in the diagnosis of celiac disease. Saborido R; Martinón N; Regueiro A; Crujeiras V; Eiras P; Leis R J Physiol Biochem; 2018 Feb; 74(1):153-158. PubMed ID: 28815514 [TBL] [Abstract][Full Text] [Related]
20. Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease. Yokoyama S; Takada K; Hirasawa M; Perera LP; Hiroi T J Clin Immunol; 2011 Dec; 31(6):1038-44. PubMed ID: 21938511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]